AzTrials
AzTrials

Musculoskeletal DiseasesWMSDNCT04192604

Work-related MusculoSkeletal Disorders Questionnaire

An observational study of Musculoskeletal Diseases and Work-Related Condition, run by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Development and validation of a multi-factor and self-perceived risk assessment questionnaire, specifically referred to WMSDs-related pain and risk factors Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
What is being tested?
WMSDsQ
How many people
115 participants
Where
No sites listed yet
Study dates
15 Jan 2020to 30 Nov 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: The sample size was set at 115 subjects. This number was established on the basis of available data deriving from surveys previously carried out in the same type of population. The test-retest will be submitted to 20 subjects. The sample will be selected randomly from a numerical generator at intervals between 1 and n (with n = highest registration number of the center workers) among the workers of the IRCCS Istituto Ortopedico Galeazzi. Furthermore, to obtain a homogeneous distribution, the sample will be evaluated according to the type of work and according to it will be stratified into 3 categories: health workers, administrative workers, other workers. The inclusion of the subjects in each category will be interrupted when they reach 40% of the total sample. In this way, the maximum possible inhomogeneity of the sample will be 40%-40%-20%.

Who may be able to join

  • Understanding of the Italian language
  • Worker of the IRCCS Istituto Ortopedico Galeazzi

Who cannot join

  • Previous surgery for musculoskeletal disorders

About this study

Official title: Development and Validation of the Work-related MusculoSkeletal Disorders Risk Assessment Questionnaire

Development and validation of a multi-factor and self-perceived risk assessment questionnaire, specifically referred to WMSDs-related pain and risk factors

Read the detailed description

The World Health Organization (WHO) has defined a WMSD as one musculoskeletal disorder (MSD) that results from a number of factors, and where the work environment and the performance of the work contribute significantly, but in varying magnitude, to the causation of the disease. The term MSD denotes health problems of the musculoskeletal system, i.e. muscles, tendons, the skeleton, cartilage, the vascular system, ligaments and nerves; ranging from light and transitory disorders to disabling injuries and permanent disability, with the loss of employment. WMSDs are in general not caused by one specific, but by multiple risk factors. These include physical (e.g. manual handling of loads, working in awkward postures, repetitive work and working at high speed, exposure to vibrations) as well as psychosocial (work stress, pain believes, sleep disturbances) factors. Consequently, a holistic preventive approach is currently needed. In order to tackle WMSDs, three different levels of prevention can be used to categorise these strategies: i) primary prevention includes the risk assessment process and technical/ergonomic, organisational and person-oriented interventions; ii) secondary prevention involves the identification and health monitoring of workers at risk; and iii) tertiary prevention comprises return-to-work actions.

The answer to the WMSDs problems in companies is holistic prevention, taking into account multifactorial risks for every individual, in order to propose a tailored educational program to every worker need

The study aims to develop and validate a multi-factor and self-perceived risk assessment questionnaire, specifically referred to WMSDs-related pain and risk factors

Gathering information and collecting data on the target population and WMSDs related risk factors:

  • Basic characteristics of the target populations (e.g. age, sex, work conditions etc.)
  • Potential work-related risk factors (e.g. repetitive motion, static posture, etc.)
  • Which of WMSDs affect more the target populations (e.g. back pain, neck pain, upper limb pain, etc.)
  • Potential effects of these and related domains (quality of life, pain, number of days of absence from work etc.)
Being tested
WMSDsQ
Keywords
Work-related musculoskeletal pain, pain management, prevention, screening
Medical subject headings
Musculoskeletal Diseases, Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • WMSDsQOther

    Work-related MusculoSkeletal Disorders Questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Development and validation

    Development and validation of a multi-factor and self-perceived risk assessment questionnaire, specifically referred to WMSDs-related pain and risk factors

    Measured: November 2019 - August 2020 (9 months)

Secondary outcomes (1)
  1. Risk Factors

    Estimation of potential work-related risk factors of WMSDs.

    Measured: November 2019 - August 2020 (9 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Dec 2019
  2. Study start15 Jan 2020 (estimated)
  3. Primary completion30 Aug 2020 (estimated)
  4. Study completion30 Nov 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
115 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04192604
Sponsor's protocol ID
WMSDsQ
Acronym
WMSD
Status last verified
Nov 2019
First submitted
21 Nov 2019
Last updated
10 Dec 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Langella F, Vanni D, Hogh M, Palsson TS, Christensen SWM, Bellosta-Lopez P, Villafane JH, Jensen PS, Silva PB, Herrero P, Barletta P, Domenech-Garcia V, Berjano P; Prevent for Work Study Group. Development of the Prevent for Work Questionnaire (P4Wq) for the assessment of musculoskeletal risk factors in the workplace: part 2-pilot study for questionnaire development and validation. BMJ Open. 2021 Dec 24;11(12):e053988. doi: 10.1136/bmjopen-2021-053988.

    PubMed 34952882

Questions about this trial

What is this clinical trial studying?

An observational study of Musculoskeletal Diseases and Work-Related Condition, run by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Dec 2019. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Development and validation (time frame: November 2019 - August 2020 (9 months)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04192604, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Dec 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in